ZIC1 and medulloblastoma: Because the ZIC1/ZIC4 locus can be targeted by both genetic- and chromatin-based mechanisms, we examined the overall proportion of samples within the validation cohort medulloblastomas (251 tumors with RNA-seq and WGS) affected by either chromatin or genetic variants.